Diagnostic Approach to Elevated Absolute Myelocytes and Monocytes

Initial Evaluation

The American Society of Hematology recommends a complete blood count with differential to identify concurrent cytopenias, thrombocytopenia, or leukopenia in patients with elevated absolute myelocytes and monocytes 1
Peripheral blood smear examination is mandatory to assess monocyte morphology, presence of dysgranulopoiesis, promonocytes, blasts, and other dysplastic features 1
A comprehensive metabolic panel including liver function tests is necessary for patients with elevated absolute myelocytes and monocytes 1

The National Comprehensive Cancer Network recommends bone marrow biopsy for patients with persistent unexplained monocytosis without clear reactive cause 1
Aspirate examination of at least 500 nucleated cells to assess blast percentage is necessary for accurate diagnosis 1, 2
Nonspecific esterase (NSE) staining showing diffuse cytoplasmic activity in monoblasts is a crucial diagnostic test 1, 2
Conventional cytogenetic analysis to exclude t(9;22), t(5;12), Philadelphia chromosome, and BCR-ABL1 fusion gene is essential for diagnosis 1
Molecular testing for mutations commonly found in CMML (TET2, SRSF2, ASXL1, RAS) and other myeloid neoplasms is necessary for accurate diagnosis 1
Immunophenotyping using multiparameter flow cytometry is a critical diagnostic tool 1, 2

The World Health Organization classification requires monocytes <1 × 10⁹/L for MDS diagnosis, and patients with monocytosis below 1000/μL can occur in MDS 3, 4
Absolute monocytosis >1000/μL is the defining criterion for Chronic Myelomonocytic Leukemia (CMML) 1

Patients should be examined for splenomegaly, lymphadenopathy, and cutaneous lesions indicating underlying hematologic malignancy 1
Assess for constitutional symptoms (fever, night sweats, weight loss) or organomegaly 1

If bone marrow blasts are 5-9%, this suggests RAEB-1, according to the World Health Organization classification 3, 4
If bone marrow blasts are 10-19%, this suggests RAEB-2, according to the World Health Organization classification 3, 4
If bone marrow blasts are ≥20%, this meets criteria for acute myeloid leukemia, according to the American Society of Hematology 2